Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, Hideki Fujii, Eiji Miyoshi, Atsushi Nakajima. Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review. Journal of gastroenterology. 2024
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, et al. Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH. European radiology. 2024
Jeffrey V Lazarus, William Alazawi, Ron Basuroy, Laurent Castera, Dmitrii Estulin, Yiannoula Koulla, Preethy Prasad, Manuel Romero-Gomez, Hirokazu Takahashi, Vincent Wai-Sun Wong, et al. A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study. Annals of hepatology. 2024. 101741-101741
Ryuki Hashida, Takumi Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Machiko Kawaguchi, Hirokazu Takahashi, Hiroshi Tajima, Hiroo Matsuse, Pegah Golabi, Lynn H Gerber, et al. Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease. European journal of gastroenterology & hepatology. 2024
Asumi Yamazaki, Yuka Takachi, Hirokazu, Takahashi Nagisa Hara, Yuji Ogawa, Hideyuki Hyogo, Masahiro, Koseki, Mariko Hayakawa, Atsushi Nakajima Michihiro, et al. Quantitative color analysis of the diets of patients with metabolic dysfunction-associated steatotic liver disease: Comparative study with nutritionally balanced diets. Hepatology Research. 2024
